Skip to main content

Nevada To Get $285M In Opioid Settlement From Walgreens

Nevada To Get $285M In Opioid Settlement From Walgreens

Introduction

Nevada’s top attorney stated that the state of Nevada and Walgreens have negotiated a $285 million settlement over the pharmacy chain's contribution to the opioid crisis.

The final of many multiyear agreements with drug makers, merchants, and other parties, it brings Nevada's estimated payouts for opioid claims to $1.1 billion, according to a news release from the state's attorney general. The number of states that have achieved settlements, which now exceed $50 billion nationwide, includes Nevada.

According to the attorney general, one of his main concerns when he initially assumed office as attorney general was to seek justice for people who had been injured by the opioid crisis.

An email from a business spokesman stated that Walgreens had no comments on the settlement. The state sued in 2019, and Walgreens is the last defendant listed.

The state and the signatories of the One Nevada Agreement, a partnership of Nevada county and local governments, will share the $285 million settlement over 15 years.

About $98.1 million will be kept by the state, and it will go into a fund established to aid in funding opioid rehabilitation programmes run by the state Department of Health and Human Services. About $116.2 million will be given to the coalition.

The state agreed to pay Teva Pharmaceuticals $193 million in June, and CVS $152 million in May. A significant portion of the more than $50 billion acquired via countrywide settlements will be utilised to address an overdose issue connected to more than 100,000 fatalities each year in the United States.

In order to resolve litigation about the harm caused by opioids, CVS agreed to pay roughly $5 billion to state and municipal governments last year. But in order to seek the single-state settlement, Nevada chose not to participate in that case.

In April 2022, Nevada signed another multistate deal worth $232 million over almost two decades with three of the major opioid producers in the country.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!